Le NgocDiep T. MD, PhD 4
4 · Verastem, Inc. · Filed Oct 11, 2017
Insider Transaction Report
Form 4
Verastem, Inc.VSTM
Le NgocDiep T. MD, PhD
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-10-09+300,000→ 300,000 totalExercise: $4.63Exp: 2027-10-09→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]25% of this option will vest on October 9, 2018 and 6.25% of this option will vest at the end of each successive three-month period thereafter until October 9, 2021.